Summary

  • Marvell's Celestial AI contingent consideration can require approximately US$233 million of cash and 22.4 million shares through fiscal 2029. Its fair value depends on forecast revenue and milestone probability as well as Marvell's share price and volatility.
  • A US$300 million cash-settled forward was entered into to manage the share-price exposure, but it has a twelve-month term. The public filing does not say it covers the full earnout, the revenue variable or the later milestone years.
  • The net contingent-consideration and forward charge fell from US$250.7 million in fiscal Q1 2027 to US$52.0 million in Q2. That US$198.7 million reduction helped the sequential GAAP-profit bridge without settling the obligation.
  • The operating quarter was also stronger: revenue reached US$2.7393 billion, operating income US$459.7 million and operating cash US$605.5 million. The correct analysis keeps operating performance, fair-value measurement and eventual settlement in separate ledgers.

One acquisition, two maturities

Marvell bought Celestial AI on 2 February 2026. The purchase put a photonic scale-up interconnect platform inside a company whose data-centre revenue is already being pulled by AI infrastructure. It also created an obligation that cannot be read from the purchase price alone.

The fiscal-Q1 Form 10-Q records US$3.5374 billion of total consideration. That included US$1.2797 billion in cash, US$1.9290 billion of Marvell stock, US$12.9 million of replacement awards attributed to pre-combination service and US$315.8 million of contingent consideration. The preliminary allocation put US$2.4044 billion into goodwill and US$951.0 million into acquired intangibles.

The contingent part remains open. If specified revenue milestones are achieved, Marvell may have to deliver additional cash and common shares through fiscal 2029. The post-close filing gives a maximum potential settlement of about US$233.0 million in undiscounted cash and approximately 22.4 million shares.

Against that exposure, Marvell entered a cash-settled forward stock purchase contract in April. Its notional amount is US$300.0 million and its term is twelve months. A risk disclosure describes maturity as approximately one year from 31 March 2026, subject to early termination.

Those dates do not match. The forward can reach settlement around spring 2027, while the earnout's performance window continues through fiscal 2029. The instrument may be renewed, replaced, resized or allowed to expire, but the checked filings promise none of those outcomes. Describing it as a complete hedge would turn an unanswered capital decision into an assumed fact.

The forward manages a price, not a business milestone

The contingent liability is measured at fair value using a Monte Carlo model and sits in Level 3 of the hierarchy. Marvell identifies forecast Celestial revenue, the probability of achieving the milestones, its own share price, stock-price volatility and other assumptions as critical inputs.

The forward has a narrower stated purpose: managing exposure to changes in Marvell's share price related to the contingent consideration. It is also Level 3, using historical stock volatility and Marvell's credit spread as unobservable inputs. Its value moves through Other expense, net, alongside the contingent-liability remeasurement.

The distinction is economic, not semantic. A forward on Marvell stock can offset some movement caused by the price of the shares that might eventually be issued. It does not make Celestial reach a cumulative revenue threshold. It cannot by itself remove the probability that no milestone, an intermediate milestone or the full milestone is achieved. Nor does a US$300 million notional establish the portion of a potential 22.4 million-share obligation that is protected; the public note does not provide the full payoff formula.

Timing adds a second boundary. Even a well-designed one-year offset leaves a decision when the contract matures. If the performance obligation remains open, Marvell will face the then-current cost of extending protection or will carry the remaining exposure. The share price, credit spread, forecast revenue and option-like milestone probability may all be different at that point.

The Q2 mark became smaller, not zero

The first two quarters show the instruments moving in the intended opposite direction without cancelling each other.

In Q1, the contingent-consideration liability increased by US$331.8 million. The forward produced an unrealised gain of US$81.1 million and appeared as a current asset of the same amount at 2 May. The net special item was therefore a US$250.7 million expense, and the contingent liability ended Q1 at US$647.6 million.

In Marvell's fiscal-Q2 results, the liability fair-value change was US$101.9 million and the forward gain was US$49.9 million. The net expense was US$52.0 million. Across the first half, the corresponding totals were US$433.7 million, US$131.0 million and US$302.7 million.

The sequential net charge fell by US$198.7 million. That is a major part of the bridge from Q1 GAAP net income of US$34.5 million to Q2's US$308.0 million. It is not cash collected, and it is not proof that the contractual maximum declined. A smaller mark can follow from any combination of share price, volatility, forecast revenue, milestone probability, discounting and model interaction. The earnings release does not separate those drivers.

Nor does the release publish the Q2 closing liability or forward-asset balance. The US$647.6 million liability belongs to 2 May, not 1 August. Carrying it forward as if it were a Q2 balance would confuse a period-opening receipt with a current measurement. The next Form 10-Q should provide the missing Level 3 bridge.

Operating improvement is a separate fact

The accounting movement should not be used to wave away a strong operating quarter. Revenue reached a record US$2.7393 billion, up 37% year on year and 13% sequentially. Data-centre revenue rose 46% year on year and 18% from Q1 to US$2.1715 billion, or 79% of the company total.

GAAP operating income increased to US$459.7 million from US$339.4 million in Q1. That US$120.3 million improvement occurred above the contingent-consideration and forward marks. Operating cash was US$605.5 million. These are receipts from a business with real AI demand, not artefacts of the Monte Carlo model.

They are also not interchangeable with net income. Operating cash was lower than Q1's US$638.8 million even as GAAP net income rose by US$273.5 million. The reconciliation adds back US$326.2 million of stock compensation, US$214.9 million of acquired-intangible amortisation and the US$52.0 million net earnout item, then absorbs working-capital changes. Non-GAAP net income of US$865.9 million answers another question again; it excludes several costs and valuation items, not just the earnout.

Marvell guided Q3 revenue to US$3.150 billion, plus or minus 5%, and expects continued data-centre acceleration. That improves the capacity to carry acquisition obligations. It does not identify Celestial's Q2 contribution. Q1 said Celestial revenue and earnings since closing were not material, while the completion announcement expected initial contribution only in the second half of fiscal 2028. Investors should not assign current custom-product growth to Celestial without a disclosed bridge.

Settlement converts measurement into liquidity

Fair-value changes are non-cash when recorded, but the contracts can end in cash and shares. The earnout includes both forms of consideration. The forward is cash-settled. Marvell warns that a fall in its stock price relative to the forward price could require a significant cash payment at settlement or early termination.

That creates a timing problem the income statement cannot solve. A quarter with a favourable offset can still precede an unfavourable cash settlement. A quarter with a large liability charge can precede strong Celestial revenue that raises the company's operating value. Measurement, operating delivery and liquidity are related, but they do not arrive together.

The forward counterparty introduces another surface. Registration of hedge shares can affect settlement mechanics, while the counterparty's hedging and resale activity can affect Marvell-share volatility. The filing does not name the counterparty. It would be improper to infer that it is NVIDIA or any other strategic investor merely because NVIDIA separately bought US$2 billion of preferred stock.

Marvell has therefore not purchased certainty. It has purchased a bounded offset for one market variable and one period. The decision after that period—renew, replace, resize or run unhedged—will reveal how management weighs premium or financing cost against a still-open fiscal-2029 obligation.

Three ledgers for the next filing

The first ledger is operational: Celestial revenue, design conversions, margin and cash contribution against the fiscal-2028 and fiscal-2029 ramp described at closing. The earnout formula is not public, so those management targets must not be mistaken for the legal thresholds.

The second is valuation: opening and closing contingent-liability value, forward value, forecast-revenue changes, milestone probabilities, Marvell's share price, volatility and credit spread. Without that bridge, the US$52.0 million net Q2 charge cannot be attributed to one assumption.

The third is settlement: maximum cash, maximum shares, diluted share count, forward maturity, any replacement contract and actual cash paid. This ledger becomes more important as the one-year clock approaches its end.

The Q2 result shows why all three are necessary. The operating engine strengthened. The net accounting charge shrank. The long-dated obligation remained open. None of those facts cancels the other two.

Sources